Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Biohaven Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Bexorg Partners with Biohaven using AI brain platform for CNS Drug Development
Details : Bexorg's brain platform will demonstrate target engagement in relevant tissues, generate biomarkers, PK/PD data & mechanistic insights for Biohaven's 2 preclinical programs.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Biohaven Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration